There are a number of clinical and epidemiological variables such as transmission, regional drug administration policies, and target populations (ie. pregnant women, co-infections, etc.)that may better explain the reported frequency of the dhfr triple mutant and dhps double mutant genotypes but could not be examined in this analysis. Here, DHPS is linked to coinfection.